Libtayo recalls
Libtayo products have been recalled 1 time, most recently on 26 Aug 2026. The recalling company is usually Regeneron Pharmaceuticals. The most common reason is sterility.
Total recalls1since 2026
Last 12 months1reported
Class I00% of total
Ongoing1latest 26 Aug 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why libtayo is recalled
Companies
Product types
By year
Ongoing libtayo recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Libtayo (cemiplimab-rwlc) Injection, 350 mg/ (50 mg/mL) recalledLibtayo | Regeneron Pharmaceuticals | Sterility | Nationwide |
All libtayo recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Libtayo (cemiplimab-rwlc) Injection, 350 mg/ (50 mg/mL) recalledLibtayo | Regeneron Pharmaceuticals | Sterility | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.